miR-422a can inhibit the TGF-β/SMAD pathway by downregulating sulfatase 2 and hence constrain NSCLC cell proliferation, migration, invasion, colony formation, epithelial–mesenchymal transition (EMT), and tumorigenesis (16). The gene discussed is SULF2; the disease is non-small cell lung carcinoma.